Consequences of cerebroventricular insulin injection on renal sodium handling in rats: effect of inhibition of central nitric oxide synthase

In the present study, we investigated the effects of acute intracerebroventricular (icv) insulin administration on central mechanisms regulating urinary sodium excretion in simultaneously centrally NG-nitro-L-arginine methylester (L-NAME)-injected unanesthetized rats. Male Wistar-Hannover rats were randomly assigned to one of five groups: a) icv 0.15 M NaCl-injected rats (control, N = 10), b) icv dose-response (1.26, 12.6 and 126 ng/3 µL) insulin-injected rats (N = 10), c) rats icv injected with 60 µg L-NAME in combination with NaCl (N = 10) or d) with insulin (N = 10), and e) subcutaneously insulin-injected rats (N = 5). Centrally administered insulin produced an increase in urinary output of sodium (NaCl: 855.6 ± 85.1 Ä percent/min; 126 ng insulin: 2055 ± 310.6 Ä percent/min; P = 0.005) and potassium (NaCl: 460.4 ± 100 Ä percent/min; 126 ng insulin: 669.2 ± 60.8 Ä percent/min; P = 0.025). The urinary sodium excretion response to icv 126 ng insulin microinjection was significantly attenuated by combined administration of L-NAME (126 ng insulin: 1935 ± 258.3 Ä percent/min; L-NAME + 126 ng insulin: 582.3 ± 69.6 Ä percent/min; P = 0.01). Insulin-induced natriuresis occurred by increasing post-proximal sodium excretion, despite an unchanged glomerular filtration rate. Although the rationale for decreased urinary sodium excretion induced by combined icv L-NAME and insulin administration is unknown, it is tempting to suggest that perhaps one of the efferent signals triggered by insulin in the CNS may be nitrergic in nature.

Effect of intracerebroventricularly injected insulin on urinary sodium excretion by cerebroventricular streptozotocin-treated rats

Recent evidence suggests that insulin may influence many brain functions. It is known that intracerebroventricular (icv) injection of nondiabetogenic doses of streptozotocin (STZ) can damage insulin receptor signal transduction. In the present study, we examined the functional damage to the brain insulin receptors on central mechanisms regulating glomerular filtration rate and urinary sodium excretion, over four periods of 30 min, in response to 3 æl insulin or 0.15 NaCl (vehicle) injected icv in STZ-treated freely moving Wistar-Hannover rats (250-300 g). The icv cannula site was visually confirmed by 2 percent Evans blue infusion. Centrally administered insulin (42.0 ng/æl) increased the urinary output of sodium (from 855.6 ± 85.1 to 2055 ± 310.6 delta percent/min; N = 11) and potassium (from 460.4 ± 100 to 669 ± 60.8 delta percent/min; N = 11). The urinary sodium excretion response to icv insulin microinjection was markedly attenuated by previous central STZ (100 æg/3 æl) administration (from 628 ± 45.8 to 617 ± 87.6 delta percent/min; N = 5) or by icv injection of a dopamine antagonist, haloperidol (4 æg/3 æl) (from 498 ± 39.4 to 517 ± 73.2 delta percent/min; N = 5). Additionally, insulin-induced natriuresis occurred by increased post-proximal tubule sodium rejection, despite an unchanged glomerular filtration rate. Excluding the possibility of a direct action of STZ on central insulin receptor-carrying neurons, the current data suggest that the insulin-sensitive response may be processed through dopaminergic D1 receptors containing neuronal pathways

Taquicardia atrial e funçäo renal / Atrial tachycardia and renal function

A taquicardia atrial induzida artificialmente em cäo produziu nas nossas condiçöes, alteraçäo importante da funçäo renal. Essa alteraçäo se manifestou por significativo aumento do volume urinário por minuto (1,3 ñ 0,12 no controle para 3,2 ñ 0,6ml/min no experimental) e da fraçäo de excreçäo de sódio (FENa) (de 2,3 ñ 0,3 no controle para 3,6 ñ 0,5), na presença de queda significante do fluxo sanguíneo renal (317 ñ 30,9 para 232 ñ 26,7 ml/min), sem alterar o ritmo de filtraçäo glomerular (66,1 ñ 6,7 no controle para 70,6 ñ 6,5 ml/min no experimental). Quanto à hemodinâmica sistêmica, observamos queda signficante do débito cardíaco e aumentos significantes da resistência vascular sistêmica e da pressäo de capilar pulmonar. Esses resultados demonstram que possivelmente fatores näo relacionados à hemodinâmica sistêmica, mas relacionados a alteraçöes hormonais, sejam responsáveis por estas alteraçöes